May 24, 2017 / 9:38 AM / 2 months ago

BRIEF-Morphosys: Janssen updates on development of guselkumab

1 Min Read

May 24 (Reuters) - MORPHOSYS AG:

* ANNOUNCES THAT ITS LICENSEE JANSSEN REPORTED UPDATES ON DEVELOPMENT OF GUSELKUMAB

* IN ADDITION, JANSSEN ANNOUNCED PLANS FOR THREE NEW PHASE 3 CLINICAL TRIALS WITH GUSELKUMAB Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below